iRhythm Holdings, Inc. filings document the public-company reporting of a digital health care business centered on ambulatory cardiac monitoring. Recent Form 8-K disclosures report operating results, financial condition, guidance-related exhibits, Regulation FD materials, material agreements, executive compensation policy changes, board appointments, and changes in the independent registered public accounting firm.
Proxy materials cover director elections, board and committee structure, executive compensation, equity awards, and stockholder voting matters. The filing record also documents the completed holding-company reorganization under which iRhythm Holdings became successor registrant to iRhythm Technologies, including common-stock continuity and predecessor registration-termination records.
iRhythm Holdings, Inc. (IRTC) completed its acquisition of VitalConnect, Inc. through its wholly owned subsidiary, iRhythm Technologies, Inc. VitalConnect is now a direct wholly owned subsidiary of iRhythm Technologies and an indirect wholly owned subsidiary of iRhythm Holdings. The acquisition adds mobile cardiac telemetry and multi-vitals monitoring capabilities and extends iRhythm’s portfolio across ambulatory, inpatient and hospital-to-home care.
Cash consideration was $237.5 million, subject to customary adjustments and funded from iRhythm’s balance sheet, plus up to 423,334 shares issued in connection with closing. iRhythm also provided VitalConnect $10.0 million in working capital funding between signing and closing. The transaction is expected to enhance iRhythm’s revenue growth rate beginning in 2027 while preserving its previously communicated 15% adjusted EBITDA margin target for 2027. iRhythm will provide updated 2026 financial guidance, including VitalConnect, on its third-quarter earnings call November 5, 2026. VitalConnect’s platform supports up to 30-day patient monitoring and up to 11 physiological parameters.
iRhythm Holdings, Inc. (IRTC) reports a key regulatory milestone for its pending acquisition of Vital Connect, Inc. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 expired at 11:59 p.m. Eastern Time on September 18, 2026, removing a principal U.S. antitrust clearance hurdle for the deal.
Under the Agreement and Plan of Merger, a wholly owned iRhythm subsidiary will merge with and into Vital Connect, with Vital Connect surviving as a direct wholly owned subsidiary of that subsidiary and an indirect wholly owned subsidiary of iRhythm. The acquisition is currently anticipated to close in early October 2026, subject to satisfaction or waiver of customary closing conditions. The disclosure is furnished under Regulation FD and accompanied by forward-looking statement cautions.
iRhythm Holdings, Inc. (IRTC) reported that its Chief Financial Officer, Daniel G. Wilson, sold 773 shares of common stock on September 2, 2026 at a price of $121.83 per share. According to a footnote, this sale was made to cover tax withholding and remittance obligations arising from the vesting of Restricted Stock Units.
After this transaction, he held 34,887 shares of common stock directly and an additional 100 shares indirectly through a family trust for which he serves as trustee. No transactions were reported as made under a Rule 10b5-1 trading plan.
RTW Investments, LP and Roderick Wong, M.D. report beneficial ownership of 2,182,631 shares of iRhythm Holdings, Inc. common stock, representing 6.6% of the class. The percentage is based on 32,862,408 shares outstanding as of April 23, 2026. Both RTW Investments and Dr. Wong report no sole voting or dispositive power, but shared voting and shared dispositive power over all 2,182,631 shares, which are held by certain RTW-managed funds that have the right to receive dividends and sale proceeds.
Artisan Partners Asset Management Inc., together with related entities, reports passive ownership of 1,660,307 common shares of iRhythm Holdings, Inc. This represents 5.1% of the outstanding common shares, based on 32,862,408 shares outstanding as of April 23, 2026. The group reports no sole voting or dispositive power over the shares. Instead, it has shared voting power over 1,529,086 shares and shared dispositive power over 1,660,307 shares.
The shares are held by Artisan Partners Limited Partnership, an investment adviser registered under section 203 of the Investment Advisers Act of 1940, on behalf of its discretionary clients. Those clients, rather than the Artisan entities, are entitled to dividends and sale proceeds, and to the knowledge of the filers, no individual client has an economic interest in more than 5% of iRhythm’s common shares.
iRhythm Holdings, Inc. reported a Board-level change in its audit oversight. On August 11, 2026, director Brian Yoor informed the company of his decision to resign from the Board of Directors and as a member and chair of the Audit Committee, effective August 12, 2026. The company states that his resignation is for personal reasons and is not based on any disagreement regarding operations, policies or practices. The Board has appointed existing director and Audit Committee member Karen McGinnis as the new chair of the Audit Committee, effective August 12, 2026. The report is signed by Chief Financial Officer Daniel Wilson on August 13, 2026.
iRhythm Holdings, Inc. reports that President and CEO Quentin S. Blackford had 48,534 shares of common stock credited to him upon the Compensation & Human Capital Management Committee’s determination that performance conditions for previously granted performance RSUs were met on August 7, 2026. On August 10, 2026, he sold 26,859 shares of common stock at $124.6514 per share to cover tax withholding and remittance obligations related to the vesting of those performance RSUs.
iRhythm Holdings, Inc. executive Patrick Michael Murphy, the company’s CBO and CLO, reported two equity transactions in common stock. On August 7, 2023 performance RSUs granted to him resulted in an acquisition of 13,589 shares upon determination that performance conditions were met. On August 10, 2026 he sold 7,093 shares of common stock at an average price of $124.6519 per share to cover tax withholding and remittance obligations related to the vesting of those performance RSUs. The Rule 10b5-1 trading plan box was not checked, indicating these transactions were not reported as occurring under a pre-arranged trading plan.
iRhythm Holdings, Inc. reported insider equity activity by Chief Commercial & Product Officer Chad Patterson. On August 7, 2026, he acquired 13,589 shares of common stock at no cost upon vesting of performance RSUs granted August 7, 2023. On August 10, 2026, he sold 7,093 shares of common stock at $124.6539 per share; the company states these shares were sold solely to cover tax withholding and remittance obligations related to the RSU vesting.
iRhythm Holdings, Inc. executive Sumi Shrishrimal, EVP and Chief Risk Officer, reported two common stock transactions. On August 7, 2026, she acquired 9,706 shares at no cost upon the Compensation & Human Capital Management Committee’s determination that performance conditions for previously granted performance RSUs were met. On August 10, 2026, 5,372 shares were sold at $124.6539 per share to cover tax withholding and remittance obligations related to that vesting.